A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies
Clinical trial NCT06038058 · RECRUITING
Trial details
- NCT number
- NCT06038058
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-10
- Primary completion
- 2028-08-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.